FDA green lights new breakthrough hepatitis treatment, how it works

According to the department, the Hepcludex injection is the first treatment for hepatitis delta virus (HDV) in adults lacking cirrhosis or with compensated cirrhosis. “Today’s approval fills a ...
Becker's Hospital Review

FDA approves 1st chronic HDV treatment

FDA approves 1st chronic HDV treatment Hepcludex to reduce virus levels and improve liver function in adults with hepatitis delta virus.
PharmExec

FDA Approves Hepcludex as First and Only Approved Treatment for Chronic Hepatitis Delta Virus

Chronic HDV occurs only with HBV and confers markedly higher risks of rapid progression, cirrhosis, liver failure, and ...

Gilead's drug wins first-ever US approval for deadly liver infection

May 22 (Reuters) - Gilead Sciences said on Friday that its experimental drug for a rare and deadly liver infection that had ...

FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated ...

Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will present data from the Phase 2 SOLSTICE trial evaluating the combination of tobevibart and elebsiran for chronic hepatitis delta ...